16-2071851-C-T

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_000548.5(TSC2):​c.2014C>T​(p.Pro672Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000703 in 1,422,234 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P672L) has been classified as Likely benign.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 7.0e-7 ( 0 hom. )

Consequence

TSC2
NM_000548.5 missense

Scores

4
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:5B:1

Conservation

PhyloP100: 0.562

Publications

2 publications found
Variant links:
Genes affected
TSC2 (HGNC:12363): (TSC complex subunit 2) This gene is a tumor suppressor gene that encodes the growth inhibitory protein tuberin. Tuberin interacts with hamartin to form the TSC protein complex which functions in the control of cell growth. This TSC protein complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC2 Gene-Disease associations (from GenCC):
  • tuberous sclerosis
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • tuberous sclerosis 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
  • lymphangioleiomyomatosis
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
  • tuberous sclerosis complex
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.19490254).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TSC2NM_000548.5 linkc.2014C>T p.Pro672Ser missense_variant Exon 19 of 42 ENST00000219476.9 NP_000539.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TSC2ENST00000219476.9 linkc.2014C>T p.Pro672Ser missense_variant Exon 19 of 42 5 NM_000548.5 ENSP00000219476.3

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000579
AC:
1
AN:
172620
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0000749
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
7.03e-7
AC:
1
AN:
1422234
Hom.:
0
Cov.:
33
AF XY:
0.00000142
AC XY:
1
AN XY:
704242
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
32534
American (AMR)
AF:
0.00
AC:
0
AN:
40020
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25408
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37464
South Asian (SAS)
AF:
0.00
AC:
0
AN:
81084
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48460
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5666
European-Non Finnish (NFE)
AF:
9.15e-7
AC:
1
AN:
1092844
Other (OTH)
AF:
0.00
AC:
0
AN:
58754
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:5Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Tuberous sclerosis 2 Uncertain:1Benign:1
May 06, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 07, 2021
Genome-Nilou Lab
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Uncertain:1
Feb 04, 2024
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Lymphangiomyomatosis;C1846385:Isolated focal cortical dysplasia type II;C1860707:Tuberous sclerosis 2 Uncertain:1
Feb 17, 2024
Fulgent Genetics, Fulgent Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Uncertain:1
Aug 03, 2022
GeneDx
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -

Hereditary cancer-predisposing syndrome Uncertain:1
Feb 05, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.P672S variant (also known as c.2014C>T), located in coding exon 18 of the TSC2 gene, results from a C to T substitution at nucleotide position 2014. The proline at codon 672 is replaced by serine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the available evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.073
BayesDel_addAF
Benign
-0.066
T
BayesDel_noAF
Benign
-0.14
CADD
Benign
7.7
DANN
Benign
0.75
DEOGEN2
Uncertain
0.59
D;.;.;.;.;.;.;.;.;.;.;.;D;.;D
Eigen
Benign
-0.72
Eigen_PC
Benign
-0.68
FATHMM_MKL
Benign
0.69
D
LIST_S2
Benign
0.85
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
M_CAP
Benign
0.068
D
MetaRNN
Benign
0.19
T;T;T;T;T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.70
T
MutationAssessor
Benign
1.1
L;.;.;.;L;L;.;.;.;L;.;L;.;.;.
PhyloP100
0.56
PrimateAI
Benign
0.37
T
PROVEAN
Uncertain
-2.5
N;.;.;N;.;D;.;.;N;N;.;.;.;.;D
REVEL
Uncertain
0.43
Sift
Benign
0.073
T;.;.;T;.;T;.;.;T;T;.;.;.;.;T
Sift4G
Uncertain
0.055
T;.;.;T;.;T;.;.;T;T;.;.;.;.;T
Polyphen
0.0
B;.;.;.;B;B;.;.;B;B;.;.;.;.;.
Vest4
0.26
MutPred
0.32
Gain of phosphorylation at P672 (P = 0.0124);Gain of phosphorylation at P672 (P = 0.0124);Gain of phosphorylation at P672 (P = 0.0124);.;Gain of phosphorylation at P672 (P = 0.0124);Gain of phosphorylation at P672 (P = 0.0124);Gain of phosphorylation at P672 (P = 0.0124);Gain of phosphorylation at P672 (P = 0.0124);.;Gain of phosphorylation at P672 (P = 0.0124);Gain of phosphorylation at P672 (P = 0.0124);Gain of phosphorylation at P672 (P = 0.0124);Gain of phosphorylation at P672 (P = 0.0124);Gain of phosphorylation at P672 (P = 0.0124);.;
MVP
0.96
ClinPred
0.038
T
GERP RS
2.0
Varity_R
0.041
gMVP
0.41
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1262368552; hg19: chr16-2121852; API